Registered entities
Cardior Pharmaceuticals GmbH
Reg. No. HRB214001Germany
Cardior Pharmaceuticals GmbH
Reg. No. P2305_HRB214001Germany
Innovation
1 patent family — focus: Chemistry & metallurgy; filing pace slowing. Cited 25 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Social engagement
Social engagement: 5.3K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include Life Sciences Partners, Boehringer Ingelheim Venture Fund, Bristol-Myers Squibb, BioMedPartners; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 69% |
| Private equity | 2 | 15% |
| Other / undisclosed | 2 | 15% |
Recent activity
9 Apr 2026
Event
TFmed Therapeutics Frontiers in Medicine Conference
16 Mar 2026
Event
Life Science and Biotech Meetup
19 Jan 2026
Event
HFA Winter Research Meeting on Translational Heart Failure